GROUP ONE TRADING, L.P. - BRAINSTORM CELL THERAPEUTICS ownership

BRAINSTORM CELL THERAPEUTICS's ticker is and the CUSIP is 10501E951. A total of 4 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of BRAINSTORM CELL THERAPEUTICS
ValueSharesWeighting
Q3 2023$19,429
-84.3%
97,100
+61.3%
0.00%
Q2 2023$124,012
-37.3%
60,200
+0.5%
0.00%
-100.0%
Q1 2023$197,670
+518.1%
59,900
+207.2%
0.00%
Q4 2022$31,980
-60.0%
19,500
+7.1%
0.00%
Q3 2022$80,000
+370.6%
18,200
+203.3%
0.00%
Q2 2022$17,000
-32.0%
6,000
-20.0%
0.00%
Q1 2022$25,000
-79.5%
7,500
-75.4%
0.00%
Q4 2021$122,000
-44.8%
30,500
-54.5%
0.00%
Q3 2021$221,000
-45.4%
67,000
-37.2%
0.00%
Q2 2021$405,000
-38.6%
106,700
-38.1%
0.00%
-100.0%
Q1 2021$660,000
-32.6%
172,300
-20.4%
0.00%
-50.0%
Q4 2020$979,000
-21.5%
216,400
+193.6%
0.00%
-50.0%
Q3 2020$1,247,000
-22.8%
73,700
-48.9%
0.00%
-42.9%
Q2 2020$1,615,000
+344.9%
144,100
+84.3%
0.01%
+133.3%
Q1 2020$363,000
+28.7%
78,200
+18.7%
0.00%
+50.0%
Q4 2019$282,000
-62.9%
65,900
-66.2%
0.00%
-66.7%
Q3 2019$761,000
-4.0%
195,100
-2.8%
0.01%
-14.3%
Q2 2019$793,000
+73.5%
200,700
+90.8%
0.01%
+40.0%
Q1 2019$457,000
+3164.3%
105,200
+2530.0%
0.01%
Q4 2018$14,000
+600.0%
4,000
+700.0%
0.00%
Q4 2017$2,000
-71.4%
500
-68.8%
0.00%
Q1 2017$7,000
+16.7%
1,600
-30.4%
0.00%
Q4 2016$6,0002,3000.00%
Other shareholders
BRAINSTORM CELL THERAPEUTICS shareholders Q3 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 2,371$1,073,0000.21%
GROUP ONE TRADING, L.P. 216,400$979,0000.00%
SIMPLEX TRADING, LLC 472$213,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BRAINSTORM CELL THERAPEUTICS shareholders